Market Place
Sourcing Support
Xellsmart Initiates Phase II Trial For Parkinson`s Cell Therapy
14 Apr 2026 //
PR NEWSWIRE
Xellsmart Gets 4th US FDA & China NMPA IND For MSA-P iPSC Cell
02 Mar 2026 //
PR NEWSWIRE
XellSmart Doses First Patient in Neural Cell Therapy Trial
28 Jul 2025 //
PR NEWSWIRE
XellSmart`s iPSC Cell Therapies for Parkinson`s & ALS Approved
15 Apr 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.